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The Role of Screening Blood Tests in Patients With Arterial Disease 
Attending Vascular Outpatients 
R. Pararajasingam*, A. Nasim, C. Sutton, M. J. Dennis, P. R. F. Bell and R. D. Sayers 
Department of Vascular Surgery, Leicester General Hospital NHS Trust, Gwendolen Road, Leicester, LE5 4PW, U.K. 
Objective: to evaluate the benefits of a policy of performzng screemng blood tests zn new patients wzth arterzal disease 
referred to the vascular outpatients department. 
Methods: clinical au&t over a 12-month period of all new referrals with arterial dzsease to the vascular outpatzents 
department a the Leicester General Hosp#al. 
Results: two hundred and seventy-two patients had at least one blood test performed at thezr outpatzent wsit All of 
these patzents had a full blood count performed, of which 21 results (21%) were abnormal. Further znvestlgation of 
patients with abnormal results revealed one case of bladder cancer, one case of leukaem~a and one patzent wzth polycythaemia. 
Urea and electrolytes were measured in 269 patients (99%). Of these, 26 (10%) were expectedly abnormal in patzents 
wlth known renal impairment. A further 27 patwnts (10%) were zdentified to have some degree of unrecognised renal 
impazrment. Serum non-fastzng lucose was measured in 252 patients (93%). There were 11 unexpectedly razsed results, 
but further mvestigatzon f these patients only diagnosed one of these patients as diabetic Serum cholesterol was measured 
zn 201 patzents (74%) One hundred and thtrty-two patzents (66%) had an abnormally raised serum cholesterol level Of 
these, only I2 patzents (6%) were known to have hyperhpldaemza 
Conclusions: screening new patients w~th arterial &sease in vascular outpatzents does identify szgnificant abnormahties, 
in partzcular enal impairment and hyperlipzdaemza. Correction of these abnormahtzes may reduce the morbidity associated 
wzth contrast znduced nephrotoxic acute renal fadure, and also contrzbute to secondary preventzon of vascular events 
associated with raised lipids. 
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Introduction attended the vascular outpatient clinics at Leicester 
General Hospital. These included patients with oc- 
The major isk factors for occlusive peripheral vascular clusive arterial disease of the limbs, carotid artery 
disease are smoking, diabetes, hypertension and disease and aortic aneurysms. The case notes were 
hyperlipidaemia. There is increasing evidence that reviewed to identify 272 patients (89%) who had at 
modification of these risk factors may halt progression least one of the following blood tests performed at 
of disease and reduce the risk of cardiovascular death. 1 their outpatient visit: full blood count, serum urea, 
Thus, many patients attending vascular outpatient creatinine and electrolytes, erum random blood glu- 
clinics undergo screening blood tests to identify and cose, serum lipids (total cholesterol and triglycerides) 
treat these risk factors. The aim of this study was to and plasma viscosity. The indications for referral and 
evaluate the benefits of a policy of performing screen- demographic data were collected for each patient o- 
ing blood tests in new arterial cases referred to the gether with the results of the blood tests. Abnormal 
vascular outpatients department, results were divided into those expected to be ab- 
normal and those not expected to be abnormal in order 
to determine whether a policy of screening all new 
Patients and Methods arterial cases with routine blood tests was worthwhile. 
The normal range for these parameters eported at the 
Over a 12-month period between November 1995 and Leicester General Hospital is illustrated in Table 1. 
October 1996, 304 new patients with arterial disease 
Results 
* Please address all correspondence to R Pararajasmgam, De-
partment of Vascular Surgery, Leicester General Hospital NHS Trust, Two hundred and seventy-two patients (89%) had at 
Gwendolen Road, Leicester, LE5 4PW, U K least one blood test performed at their outpatient visit. 
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Table 1. Normal values for parameters measured, to be abnormal. Three patients were already under 
Test investigation for iron deficiency anaemia, nine patients 
with normocytic anaemia had end stage renal failure 
Haemoglobin 13.5-18 g/d1 men and two had a combination of infection and general 
11 5-16.5 g/dl women 
Wtute cell count 4-11 x 10/9 per 1 debility. 
platelets 150-400 x 10/91 Seven patients (2.5%) had unexpectedly abnormal 
Sodmm 133-144mmol/1 results: one had a bladder cancer, another was diag- 
Potassmm 3.3-5.3 mmol/1 
Urea 2 5-6 5 mmol/1 nosed with leukaemia nd a final patient was diag- 
Creatmme 45-130 gmol/1 nosed with polycythaemia. No cause for anaemia was 
Glucose 4--6 6 mmol/1 found in the other four patients after investigation. Plasma VlSCOmty 15-172 centipolse 
Cholesterol 3 9-6 5 mmol/1 Urea and electrolytes were measured in 269 patients 
Tnglycendes <2 mmol/1 (99%) and 55 (20%) were abnormal. Of these, 26 (10%) 
Although the hospital reference range for cholesterol is 3 9-6 5, the were expected to be abnormal in patients with known 
desirable serum cholesterol m accordance with The British Heart chronic renal failure or impairment and were referred 
Foundation and The National Cholesterol Education Programme m to the vascular outpatients by the regional renal unit 
the U S.A is <5.2 mmol/1 
or medical colleagues. Twenty-nine (11%) were un- 
Table 2. Indication for referral of patients to the vascular out- expectedly abnormal. In two of these patients the 
patients. Figures in parentheses are percentages, abnormality was hypokalaemia induced by diuretics. 
Indicatxon Number of patmnts The remaining 27 patients were found to have varying 
degrees of renal impairment. 
Suspected occlusive &sease (upper and 200 (73.5) Serum glucose (non-fasting) was performed in 252 
lower lunb) patients (93%) and 46 (18%) were abnormal. In 35 of 
Suspected aortic aneurysm 36 (13 2) 
Other aneurysms 6 (2 2) these patients abnormal results were expected. The 
Carotzd artery &sease 25 (9 1) remaining patients were investigated with a glucose 
Others 5 (1 8) tolerance test and only one patient was found to be a 
newly diagnosed iabetic. 
Table 3. Number of patients undergoing each blood test (n= Plasma viscosity was performed on 170 patients 
272). Figures in parentheses are percentages. (63%). It was mildly raised in 32 patients and mod- 
Blood test Number of patmnts screened erately raised in a further 10 patients. 
Serum lipids (total cholesterol and tnglycerides) 
Full blood count 272 (100) were performed in 201 patients (74%). One hundred Urea and electrolytes 268 (99) 
Blood glucose 252 (93) and thirty-two (66%) had a raised serum total cho- 
Llplds 201 (74) lesterol (>5.2 mmol/1). Of these, 12 (6%) were known 
Plasma viscomty 170 (63) to have hyperl ipidaemia and were being treated with 
a combination of dietary manipulation and/or  lipid 
There were 179 males (66%) with a median age of 69 lowering agents. One hundred and twenty (60%) had 
(range 34-91) and 93 (34%) females with a median unexpectedly abnormal serum cholesterol. Eighteen of 
age of 73 (range 46-88) The indications of these 272 these patients were known to be diabetic. 
patients is shown in Table 2. The number of patients The total cost of performing these screening blood 
who underwent each investigation is shown in Table tests was £2222.99. The data illustrated in Table 6 
3. shows that screening for hypercholesterolaemia is the 
All patients underwent a full blood count (n = 272). most cost effective of these tests. 
The result was normal in 251 patients (92%). Of the Overall, 201 patients had a full blood count, plasma 
21 abnormal full blood counts (8%), 14 were expected urea and electrolytes, plasma glucose and serum lipids 
Table 4. Value of the screening policy. 
Blood test Number screened Number of Number of Percentage of 
abnormal results abnormal results that abnormal results that 
were unexpected were unexpected 
Full blood count 272 21 7 33 
Urea and Electrolytes 269 55 29 53 
Glucose 252 46 11 24 
Cholesterol 201 132 120 91 
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Table 5. Current cost of screening policy. 
Test Cost per test Number of tests Cost per year Amount spent per 
done m 1 year unexpectedly abnormal 
result 
Full blood count £2 81 272 £764 32 £109 18 
Urea and Electrolyte £2 55 269 £685 95 £23 65 
Glucose £0 64 252 £161 28 £14 60 
Plasma viscosity £2 84 170 £428.80 £48 20 
Cholesterol £0 64 201 £128 64 £1.07 
performed. Only 51 of these patients had a full set of many patients will undergo further investigation with 
normal results, contrast angiography which may precipitate contrast 
induced (nephrotoxic) acute renal failure in patients 
with pre-existing renal impairment. A baseline cre- 
Discussion atmine of <130 gmol per litre is considered a safe level 
and usually does not lead to acute renal failure after 
The conservative management of peripheral vascular angiography. 6 Early identification of patients with 
disease in the legs was summarised in five words by renal impairment allows the opportunity to correct 
Housley: "Stop smoking and keep walking". 2 Other factors contributing to renal impairment, namely dis- 
important conservative measures include control of continuing nephrotoxic medication, correcting ob- 
ischaemic heart disease, hypertension, diabetes mel- structive uropathy and initiating investigation and 
treatment for renal artery stenosis. Patients with pre- litus and hyperlipidaemia. 1 The role of aspirin in sec- 
ondary prevention of atherosclerotic disease is now existing renal impairment should be prepared for 
established.3 angiography with prehydration using isotonic crys- 
There is increasing evidence that hyperlipidaemia talloid. Renal protection with renal dose dopamine or 
manitol has also been shown to decrease the incidence is an important and treatable risk factor for the pro- 
gression of atherosclerotic disease. Recent guidelines of renal failure following contrast angiography. 6 
from the American College of Physicians uggest that Screening for diabetes mellitus with serum glucose 
all patients with known coronary artery disease, stroke, only revealed one new patient among 252 patients 
intermittent claudication or any other atherosclerotic screened. This data suggests that routine de- 
disease process should be screened and treated termination of plasma non-fasting lucose in new 
for hypercholesterolaemia. 4 Treatment of hyper- referrals to the vascular clinic has limited value, and 
cholesterolaemia in patients with atherosclerosis de- urinalysis of blood glucose test strips may be a cheaper 
creases disease progression and reduces complication alternative. Plasma viscosity is a non-specific marker 
rates making it cost-effective in the long-term. 5 of inflammation; this test provided little useful clinical 
The extent o which clinicians hould routinely per- information and seems inappropriate. 
form screening blood tests in an elderly population This data demonstrates that serum random cho- 
with many risk factors is unclear. This paper examined lesterol determination is a most useful blood test in 
the value of screening blood tests in new arterial patients with vascular disease. A large number of 
referrals to a vascular clinic. Despite the relatively patients (132 out of 201 screened) had serum cho- 
low number of abnormal full blood counts, this data lesterol levels above the desirable level of 5.2 mmol/1 
illustrates that some important abnormalities will be set by the National Cholesterol Education Programme 
determined by performing this test. Some abnormal in the U.S.A. and The British Heart Foundation i  the 
results are to be expected in the elderly population. U.K.  7 
In addition, full blood count measurement may be The current evidence suggests that secondary com- 
very useful in the management of vascular disease as plications of the atherosclerotic process, including car- 
relative anaemia will contribute to poor peripheral diac and cerebrovascular events, are responsible for 
perfusion and may exacerbate symptoms of peripheral the lower long-term survival rates of patients following 
vascular disease, major vascular surgery compared to age and sex 
Identification ofpatients with pre-existing renal im- matched populations. 8 10 Correction of lipid ab- 
pairment isvery important because itmay be reversible normalities might prevent his. 
and thus prevents ymptoms of lethargy, debility and Non-fasting serum total cholesterol is a reliable 
progression to end stage renal failure. In addition, screening test for the detection of hyperlipidaemia. 7'11
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The data suggests that there is a signif icant incidence 2 HOUSLEY E Treating claudication m five words. Brat Med J 1988, 
296 1983-1984 
of unrecognised and untreated hyper l ip idaemia in 3 DEGETANO G Primary prevenhon ofvascular dlsdase by asprln 
pat ients present ing to the vascular clinic. Lancet 1988, 8594 1093-1094 
In conclusion, the number  of abnormal  results of 4 BROWN WV. Hypercholesterolaemla  the United States. how 
far have we come? Am J Med 1997; 102 3-6. 
common blood tests was low and especial ly the rate 5 SUPERKO HR Cost effective treatment of coronary artery disease 
of unexpected abnormal i t ies was minimal .  The ex- - the new imperative Chn Car&ol 1996, 19. 650-655 
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lipids. Correct ion of these abnormal i t ies may reduce 7 AUTHORS V Summary of the second report of the national 
the morb id i ty  associated wi th  contrast induced cholesterol educational programme expert panel on the detection, 
evaluation and treatment of high blood cholesterol m adults 
nephrotoxic acute renal failure, and also contr ibute to Arch Inter Med 1993; 269:3015-3023 
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